Age, yrs
Median (range)
|
60.18 (34-85)
|
62.36 (42-85)
|
58 (34-76)
|
Sex
Male
Female
|
15 (53.57)
13 (46.43)
|
8 (57.1)
6 (42.9)
|
7 (50)
7 (50)
|
Surgical approach
Transcervical
Transcervical-transparotid
Transcervical-transmandibular
TORS alone
TORS + transcervical
|
–
1 (3.57)
11 (39.28)
2 (7.14)
12 (42.85)
2 (7.14)
|
1 (7.14)
11 (78.57)
2 (14.29)
–
–
|
–
–
–
12 (85.71)
2 (14.29)
|
Pathology of tumor
Pleomorphic adenoma
Warthin’s tumor
Carcinoma ex pleomorphic adenoma
Adenoid cystic carcinoma
Salivary duct carcinoma
Schwannoma
Hemangioma
Lipoma
Histiocytoma
Metastasis of squamous cell carcinoma
Myoepithelioma
Lymphoepithelial lesion
Liposarcoma
|
8 (28.57)
1 (3.57)
2 (7.14)
1 (3.57)
1 (3.57)
1 (3.57)
2 (7.14)
1 (3.57)
1 (3.57)
7 (25.0)
1 (3.57)
1 (3.57)
1 (3.57)
|
6 (42.85)
1 (7.14)
1 (7.14)
1 (7.14)
1 (7.14)
–
–
–
–
2 (14.28)
1 (7.14)
–
1 (7.14)
|
2 (14.28)
–
1 (7.14)
–
–
1 (7.14)
2 (14.28)
1 (7.14)
1 (7.14)
5 (35.7)
–
1 (7.14)
–
|
Type of tumor
Benign
Malignant
|
17 (60.71)
11 (39.29)
|
9 (64.29)
5 (35.71)
|
8 (57.14)
6 (42.86)
|
Mean tumor size, cm3 |
19.4 |
21.66 |
17.15 |
Mean max tumor length, cm |
3.75 |
3.6 |
3.9 |
Need for feeding tube |
8 (28.6) |
4 (28.6) |
4
(28.6) |
Mean duration of surgery, mins (range) |
182.9 (40-340) |
221.4
(100-340) |
133.3 (40-240) |
Mean length of hospital stay, days |
7.32 |
8.9 |
5.8 |
Rate of post-surgical complications |
39.3% |
64.3% |
14.3% |
Free margin rate |
75% |
75% |
75% |
2-year relapse free survival rate |
74.1% |
69.3% |
78.6% |